Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2005
12/22/2005US20050282864 Indole derivatives as H3 inverse agonists
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282857 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes
12/22/2005US20050282847 Oxidizing a 4-substituted-2-thiopyrimidine and reacting the sulfone formed with an alkylcyanamide; both thio and sulfonyl intermediates of 4-substitutedaminopyridines are claimed, e.g., 4,6-dichloro-5-(2-chloro-6-fluorophenyl)-2-methylthiopyrimidine
12/22/2005US20050282828 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
12/22/2005US20050282825 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
12/22/2005US20050282824 Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems
12/22/2005US20050282823 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282816 Pyrazinylmethyl lactam derivatives
12/22/2005US20050282815 Substituted N-(heteroar-beta-yl)aminopyridinecarboxamides or benzamides, e.g., 2-amino-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-N-(4-methylthiazol-2-yl)benzamide; glucokinase activators used to treat diabetes mellitus or obesity
12/22/2005US20050282814 Vasculostatic agents and methods of use thereof
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282809 Heteroaryl-hydrazone compounds
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282803 CIS-imidazolines
12/22/2005US20050282802 double salts of N-(3-Methyl-benzylidene)-N'-[6-morpholin-4-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-hydrazine, having improved bioavailability, solubility, melting point and stability, used for the treatment of interleukin-12 (IL-12) related diseases or disorders
12/22/2005US20050282801 Novel phenantridine analogues and uses thereof
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005CA2569883A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005CA2569404A1 Quinoline- and isoquinoline-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2568301A1 3-phenyltetrahydrocinnolin-5-ol derivatives and medicinal use thereof of
12/22/2005CA2567821A1 Quinazolinone derivatives useful as vanilloid antagonists
12/22/2005CA2567513A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005CA2564642A1 Lxr receptor modulators
12/22/2005CA2561831A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005CA2557942A1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1607395A1 Process for production of sulfoxide derivatives or salts thereof in the amorphous state
12/21/2005EP1607394A1 Water-soluble thalidomine derivatives
12/21/2005EP1606623A2 Labelling agents for mass spectrometry comprising tertiary amines
12/21/2005EP1606289A1 Carboxamide derivatives
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606283A2 P38 inhibitors and methods of use thereof
12/21/2005EP1606282A2 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
12/21/2005EP1606281A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/21/2005EP1606280A2 Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity
12/21/2005EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
12/21/2005EP1606277A1 Imidazol-4-yl-ethynyl-pyridine derivatives
12/21/2005EP1606276A1 Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
12/21/2005EP1606267A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors
12/21/2005EP1606266A2 Chemical compounds
12/21/2005EP1606265A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/21/2005EP1606264A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
12/21/2005EP1606263A1 Ring-substituted 8-aminoquinoline derivatives as antimalarial agents
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1606251A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
12/21/2005EP1605944A2 Quinoline derivatives as nk-2 and nk-3 receptor antagonists
12/21/2005EP1605936A1 Aryl spirohydantoin cgrp receptor antagonists
12/21/2005EP1605896A2 7-amino- isoindolyl compounds amd their pharmaceutical uses
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1307445B1 Benzofuran derivatives and their use as antibacterial agents
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005EP1125924B1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711347A Use of metal complex compounds as oxidation catalysts
12/21/2005CN1711256A 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
12/21/2005CN1711255A Novel anthranilamide insecticides
12/21/2005CN1711081A Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
12/21/2005CN1709870A Optical-purity N',N'-dibasic prolyl hydrazine compound, and its preparing method and use
12/21/2005CN1232508C Cyclization process step in making of quinolones and phenodiazine
12/21/2005CN1232507C Growth hormone secretagogues
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977265 Piperidine CCR-3 receptor antagonists
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977259 Quinoline derivatives and their use as aurora 2 kinase inhibitors
12/20/2005US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/20/2005CA2338206C High affinity ligands for nociceptin receptor orl-1
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/20/2005CA2302412C Aminoalkylphenol derivatives and related compounds
12/20/2005CA2233560C Sulfonamide inhibitors of matrix metalloproteinases
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/20/2005CA2114007C Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
12/15/2005WO2005118606A1 Fluorine-substituted iridium complex and luminescent material made with the same
12/15/2005WO2005118587A1 Indole derivative and use for treatment of cancer
12/15/2005WO2005118578A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005WO2005118574A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118573A1 Novel diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
12/15/2005WO2005118572A1 Quinazoline derivatives as erbb receptor tyrosine kinases
12/15/2005WO2005118571A1 Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor
12/15/2005WO2005118570A1 Butyrylcholinesterase selective inhibitors
12/15/2005WO2005118569A1 Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
12/15/2005WO2005118568A1 Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
12/15/2005WO2005118567A2 Magnesium complexes of s-omeprazole
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 1080